Retractable Tech Stock Price, News & Analysis

Retractable Technologies, Inc. (NYSE American: RVP) reported significant improvement in financial performance for the first nine months of 2021, with operating income rising to $44.1 million compared to $11.8 million in the previous year. Income applicable to common shareholders also surged to $35.0 million from $14.7 million. Net sales reached $36.4 million for Q3 2021, driven largely by orders from the U.S. government, which accounted for over 50% of total sales. Despite revenue increases, gross margins were pressured by rising transportation costs due to COVID-19 impacts.

Retractable Technologies, Inc. (NYSE American: RVP) has declared dividends of $39,050 for its Series II Class B Convertible Preferred Stock, equating to $0.25 per share. The accrued dividends at 10% per annum cover amounts from July 1, 2021 to September 30, 2021. Payment is scheduled for October 22, 2021, to shareholders on record as of October 12, 2021. This announcement highlights the company's commitment to its investors, despite potential operational risks and external market challenges.

Retractable Technologies, Inc. (NYSE American: RVP) reported a significant increase in operating income, reaching $36.1 million for the first six months of 2021, up from $1.4 million in the prior year. Income applicable to common shareholders was $28.5 million, compared to $3.7 million the previous year. Net sales for the quarter ended June 30, 2021, were $42.5 million, with the U.S. government accounting for 64.4% of sales. Domestic revenues surged 325.0%, driven by increased government orders.

Retractable Technologies, Inc. (RVP) has approved a stock repurchase plan for up to $10 million, starting June 18, 2021. This plan will run until June 18, 2022, and is designed to enhance shareholder value in response to the stock's perceived undervaluation. The company will also distribute $5,056,945 in dividends to its Class B Convertible Preferred shareholders, including amounts in arrears, with payments scheduled for July 22, 2021. CEO Thomas J. Shaw acknowledged shareholder patience and highlighted the company's commitment to providing essential safety products.

Retractable Technologies, Inc. (RVP) announced an amendment to delivery order 75A50120F33003 from the Department of Health and Human Services, extending the performance end date from May 2021 to March 2022. The amendment reallocates orders to increase shipments of 1mL low dead-space safety syringes. The total contract price and freight costs remain unchanged. The company emphasizes potential challenges, including COVID-19 impacts, liquidity issues, and foreign trade risks among others, that could affect future performance.

Retractable Technologies, Inc. (NYSE American: RVP) has received preliminary notice from the U.S. Department of Health and Human Services to exercise all seven one-month option periods under contract 75A50121P00021, extending the contract's expiration to February 14, 2022. This extension increases the contract's value by $92,772,680, covering products and freight reimbursement costs.

Retractable Technologies Inc. (NYSE American: RVP) has amended its Technology Investment Agreement with the U.S. government, securing an additional $27.4 million in funding. This increase aims to boost domestic manufacturing capabilities by at least 50% to meet ongoing COVID-19 countermeasure demands. The funding will be used to expand production of 1mL low dead-space safety syringes by adding new assembly lines and expanding facilities in Little Elm, Texas. The modification effort is scheduled to be completed by January 31, 2022.

Retractable Technologies, Inc. (NYSE American: RVP) reported a significant increase in operating income to $23.4 million for Q1 2021, a sharp rise from $481 thousand a year prior. U.S. government sales accounted for 75.5% of total revenues, highlighting a 484.7% increase in domestic sales. Additionally, the company had its $1.36 million PPP loan forgiven. However, operating expenses increased 50%, driven by higher headcount and related costs. Overall, domestic unit sales surged 282.6%, although international revenues decreased by $1.5 million.

Retractable Technologies, Inc. (RVP) received preliminary notice from the U.S. Department of Health and Human Services (HHS/ASPR) regarding its intent to exercise two one-month options under a contract dated February 2021. This move extends the contract's expiration from July 14, 2021, to September 14, 2021, correlating to an overall purchase price of approximately $23.5 million, inclusive of freight costs. The contract contains seven total option periods.